Anixa Biosciences, Inc. (ANIX)
Nasdaq: ANIX · Pharmaceutical Preparations · San Jose, CA · filing with the SEC since 1995
Who owns Anixa Biosciences, Inc.
As filed with the SECHolders of 5% or more
2
Amit Kumar holds 16.3% of Common Stock, as its SCHEDULE 13D/A filed Jun 6, 2025 says.
Directors and officers
5
report now, of 12 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Amit Kumar
SCHEDULE 13D/A · filed Jun 6, 2025 · Common Stock · 15.1% in Jan 3, 2025
Michael Catelani
SCHEDULE 13D/A · filed Jan 6, 2026 · Common Stock
What ANIX reports owning in othersstakes of 5% or more, and other ties
Anixa Biosciences, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
21purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$500,000bought, in dollars
Open-market trades on Form 4 from Nov 2, 2025 to Nov 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 12 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kumar Amit | Chief Executive Officer | 0 | $0 | 0 | 12 | $200,000 |
| Titterton Lewis H Jr | Chief Executive Officer | 0 | $0 | 0 | 6 | $200,000 |
| Baskies Arnold M | director | 0 | $0 | 0 | 2 | $0 |
| Catelani Michael | President, COO, & CFO | 0 | $0 | 0 | 1 | $0 |